SI-BONE Inc
SIBN
About: SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Employees: 349
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
6,908% more call options, than puts
Call options by funds: $1.68M | Put options by funds: $24K
118% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 17
35% more capital invested
Capital invested by funds: $567M [Q1] → $769M (+$201M) [Q2]
12% more funds holding
Funds holding: 158 [Q1] → 177 (+19) [Q2]
5% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 56
0.57% more ownership
Funds ownership: 95.28% [Q1] → 95.85% (+0.57%) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Cantor Fitzgerald
Ross Osborn
|
$25
|
Overweight
Reiterated
|
5 Aug 2025 |
Financial journalist opinion